PALL - RGA Investment Advisors - Sartorius: Purity In The Pure Play Of Bioprocessing

2024-06-11 21:45:00 ET

Summary

• Sartorius AG is a pure play in the bioprocessing industry, dominating the single-use bioreactors market with a focus on upstream flow.
• Sartorius' strong customer relationships and service-first mentality have led to impressive share gains and consistent growth over the past decade.
• Despite trading at a premium to Danaher, Sartorius' valuation dropped below Danaher's, presenting a buying opportunity for investors.

The following segment was excerpted from this fund letter.

Sartorius AG ( SARTF )

In our Q3 2023 commentary, we featured a section on our investment in Danaher ( DHR ) entitled "Purity in the Crown Jewel of Bioprocessing." Specifically, we were speaking to Cytiva, Danaher's bioprocessing business formed by the merger of PALL Corp and GE 's bioprocessing division....

For further details see: